...
首页> 外文期刊>Biological & pharmaceutical bulletin >Receptor mediated endocytosis and cytotoxicity of transferrin-mitomycin C conjugate in the HepG2 cell and primary cultured rat hepatocyte.
【24h】

Receptor mediated endocytosis and cytotoxicity of transferrin-mitomycin C conjugate in the HepG2 cell and primary cultured rat hepatocyte.

机译:受体介导的HepG2细胞和原代培养的大鼠肝细胞中转铁蛋白-丝裂霉素C共轭物的内吞作用和细胞毒性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Intracellular disposition and cytotoxicity of macromolecular conjugate of mitomycin C (MMC) with transferrin (TF) were examined in the human hepatoma cell line HepG2 cell and normal cultured rat hepatocyte. The conjugate (TF-MMC) was specifically bound to the HepG2 cell as well as TF. The number of the binding site and the association constant of TF-MMC in the HepG2 cell were 396000+/-31000 molecules/cell and 3.24 x 10(7)+/-0.58 x 10(7) M(-1), respectively. No difference in the binding parameters of TF-MMC and TF can be detected in the HepG2 cell. The association constant for the TF receptor was almost identical between HepG2 cell and hepatocyte, however, the numbers of the binding site of TF-MMC and TF in the HepG2 cell were from 40-times to 50-times greater than those in the hepatocyte. Furthermore, TF-MMC was internalized into the HepG2 cell and the hepatocyte as well as TF. The rates of internalization of TF-MMC and TF into the HepG2 cell were nearly identical to those into the hepatocyte. However, the levels of the internalization into the HepG2 cell were remarkably higher than those into the hepatocyte because the number of receptors in the HepG2 cell was larger than that in the hepatocyte, and the rate of release from the HepG2 cell was slower than that from the hepatocyte. TF-MMC inhibited the growth of the HepG2 cells. The 50% growth inhibition (GI50) of TF-MMC against the HepG2 cell was 0.9 microg MMC/ml, which was a little higher than that of MMC (GI50=0.5 microg/ml). These results indicated that the TF-MMC might be useful for delivery of MMC to the HepG2 cell.
机译:在人肝癌细胞系HepG2细胞和正常培养的大鼠肝细胞中检查了丝裂霉素C(MMC)与转铁蛋白(TF)的大分子偶联物的细胞内处置和细胞毒性。结合物(TF-MMC)与TF和HepG2细胞特异性结合。 HepG2细胞中TF-MMC的结合位点数和缔合常数分别为396000 +/- 31000分子/细胞和3.24 x 10(7)+/- 0.58 x 10(7)M(-1) 。在HepG2细胞中,无法检测到TF-MMC和TF的结合参数的差异。 HepG2细胞与肝细胞之间TF受体的缔合常数几乎相同,但是,HepG2细胞中TF-MMC和TF的结合位点数是肝细胞中TF-MMC和TF结合位点的40倍至50倍。此外,TF-MMC被内化到HepG2细胞和肝细胞以及TF中。 TF-MMC和TF进入HepG2细胞的内在化速率与进入肝细胞的速率几乎相同。但是,由于HepG2细胞中的受体数量大于肝细胞中的受体数量,并且从HepG2细胞中释放的速率比从HepG2细胞中释放的速率要慢,因此内化到HepG2细胞中的水平明显高于进入肝细胞中的水平。肝细胞。 TF-MMC抑制了HepG2细胞的生长。 TF-MMC对HepG2细胞的50%生长抑制(GI50)为0.9 microg MMC / ml,略高于MMC(GI50 = 0.5 microg / ml)。这些结果表明,TF-MMC对于将MMC递送至HepG2细胞可能有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号